StockDrifts LogoStockDrifts

Sapporo Clinical Laboratory Inc. 9776

Company
札幌臨床検査センター株式会社Sapporo Clinical Laboratory Inc.
Investors
7
Buys
5
Total Value
¥84M ($544K)
Avg Return
-0.52%
Last Filing
2026-02-18

Sapporo Clinical Laboratory Inc. (9776) has 5 disclosed large-shareholding filings and 6 disclosed disposals on record, filed by 7 distinct investors. Together those filings cover ¥84M ($544K) in reported transaction value. The earliest filing StockDrifts holds for Sapporo Clinical Laboratory Inc. is dated 2022-06-07; the most recent is 2026-02-18. All of it is parsed from EDINET large-shareholding (5%+) reports, the official disclosure system operated by the Financial Services Agency (Japan). Across these filings the average return since disclosure is -0.52%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent filings

DateTypeSourceInsiderPurposeSharesPrice at filingReturnValue
2026-02-18BUYMarket Buy
エピック・パートナーズ・インベストメンツ株式会社
Epic Partners Investments Co., Ltd.
activist399.1K¥1,960-0.4%¥84M ($544K)
2026-01-27BUYMarket Buy
エピック・パートナーズ・インベストメンツ株式会社
Epic Partners Investments Co., Ltd.
activist356.1K¥1,965-0.7%¥109M ($706K)
2026-01-27BUYunknown
エピック・パートナーズ・インベストメンツ株式会社
Epic Partners Investments Co., Ltd.
activist356.1K¥1,965-0.7%¥109M ($706K)
2026-01-21BUYMarket Buy
エピック・パートナーズ・インベストメンツ株式会社
Epic Partners Investments Co., Ltd.
activist300.4K¥1,963-0.6%¥89M ($571K)
2025-12-25BUYunknown
エピック・パートナーズ・インベストメンツ株式会社
Epic Partners Investments Co., Ltd.
activist255.3K¥1,964-0.6%¥84M ($540K)
2025-12-25BUYMarket Buy
エピック・パートナーズ・インベストメンツ株式会社
Epic Partners Investments Co., Ltd.
activist255.3K¥1,964-0.6%¥84M ($540K)
2025-12-15BUYacquisition
エピック・パートナーズ・インベストメンツ株式会社
Epic Partners Investments Co., Ltd.
activist212.7K¥1,959-0.4%¥417M ($2.7M)
2025-12-15BUYunknown
エピック・パートナーズ・インベストメンツ株式会社
Epic Partners Investments Co., Ltd.
activist212.7K¥1,959-0.4%¥417M ($2.7M)
2025-11-14BUYunknown
伊達 祐子
Yuko Date
activist6.2K¥1,959-0.4%¥12M ($78K)
2025-11-14BUYunknown
伊達 忠應
Tadao Date
activist62.4K¥1,959-0.4%¥122M ($789K)
2025-11-14BUYunknown
伊達 忠一
Chuichi Date
activist126.4K¥1,959-0.4%¥248M ($1.6M)
2025-11-14BUYunknown
伊達アセットマネ-ジメント合同会社
Date Asset Management LLC
activist1.2M¥1,959-0.4%¥2.3B ($15.0M)
2024-04-24BUYunknown
株式会社LSIメディエンス
LSI Medience Corporation
other0¥1,082+80.4%¥228M ($1.5M)
2024-04-19BUYunknown
株式会社LSIメディエンス
LSI Medience Corporation
other210.8K¥1,091+78.9%¥230M ($1.5M)
2024-01-22SELLunknown
エフエムアール エルエルシー(FMR LLC)
FMR LLC
other154.6K¥1,019-91.6%¥60M ($388K)
2023-12-07SELLunknown
エフエムアール エルエルシー(FMR LLC)
FMR LLC
other213.8K¥997-95.8%¥43M ($277K)
2023-10-20SELLunknown
エフエムアール エルエルシー(FMR LLC)
FMR LLC
other256.8K¥1,000-95.2%¥54M ($345K)
2023-08-22SELLunknown
エフエムアール エルエルシー(FMR LLC)
FMR LLC
other310.5K¥1,004-94.4%¥44M ($281K)
2023-07-05SELLunknown
株式会社LSIメディエンス
LSI Medience Corporation
other210.8K¥1,130-72.7%¥44M ($286K)
2022-06-07SELLunknown
エフエムアール エルエルシー(FMR LLC)
FMR LLC
other353.6K¥1,278-52.7%¥57M ($368K)

Frequently asked questions

Who has been buying Sapporo Clinical Laboratory Inc. stock?
7 distinct investors have filed 5 disclosed large-shareholding filings in Sapporo Clinical Laboratory Inc. (9776), most recently on 2026-02-18. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Sapporo Clinical Laboratory Inc. have?
Sapporo Clinical Laboratory Inc. has 5 buy-side and 6 sell-side disclosures on record, covering ¥84M ($544K) in total reported value, spanning 2022-06-07 to 2026-02-18.
Where does StockDrifts get Sapporo Clinical Laboratory Inc. insider data?
From EDINET large-shareholding (5%+) reports — the official filing system run by the Financial Services Agency (Japan). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from EDINET.
Do insider buys in Japanese stocks predict returns?
Not uniformly. StockDrifts scored 101,000+ Japanese large-shareholding filings on fixed 12-month forward returns and found the predictive power concentrated in specific filer types and filing patterns rather than spread evenly across all disclosures.

Source filings

Every trade listed above is disclosed in EDINET large-shareholding (5%+) reports, filed with the Financial Services Agency (Japan). View the original EDINET filings for Sapporo Clinical Laboratory Inc.. For how StockDrifts scores these disclosures, see the Japan insider signal tier research, or browse every Japanese stock we track.